Showing results (21-30 of 33) with videos related to
Sort By:
Pageof 4
The Journal of Urology|July 13, 2004
Evidence supporting preoperative chemotherapy for small cell carcinoma of the bladder: a retrospective review of the M. D. Anderson cancer experienceArlene O Siefker-Radtke, Colin P Dinney, Neil A Abrahams, et al.Urology|February 7, 2007
Chemotherapy for bladder cancer: treatment guidelines for neoadjuvant chemotherapy, bladder preservation, adjuvant chemotherapy, and metastatic cancerCora N Sternberg, S Machele Donat, Joaquim Bellmunt, et al.Urologic Oncology|October 12, 2010
Survival outcomes for men with mediastinal germ-cell tumors: the University of Texas M. D. Anderson Cancer Center experienceAlan J Rodney, Nizar M Tannir, Arlene O Siefker-Radtke, et al.The Journal of Urology|February 14, 2006
The case for early cystectomy in the treatment of nonmuscle invasive micropapillary bladder carcinomaAshish M Kamat, Jason R Gee, Colin P N Dinney, et al.The Canadian Journal of Urology|June 23, 2010
Early results of chemotherapy with retroperitoneal lymph node dissection for isolated retroperitoneal recurrence of upper urinary tract urothelial carcinoma after nephroureterectomyM Adam Childs, Christopher G Wood, Philippe E Spiess, et al.European Urology|September 7, 2015
A Prognostic Gene Expression Signature in the Molecular Classification of Chemotherapy-naïve Urothelial Cancer is Predictive of Clinical Outcomes from Neoadjuvant Chemotherapy: A Phase 2 Trial of Dose-dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin with Bevacizumab in Urothelial CancerDavid J McConkey, Woonyoung Choi, Yu Shen, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 29, 2009
Phase II presurgical feasibility study of bevacizumab in untreated patients with metastatic renal cell carcinomaEric Jonasch, Christopher G Wood, Surena F Matin, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|August 3, 2016
A Phase l Study of a Tumor-targeted Systemic Nanodelivery System, SGT-94, in Genitourinary CancersArlene Siefker-Radtke, Xin-Qiao Zhang, Charles C Guo, et al.The Journal of Urology|August 6, 2013
Refining patient selection for neoadjuvant chemotherapy before radical cystectomyStephen H Culp, Rian J Dickstein, H Barton Grossman, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2004
Phase I trial of the proteasome inhibitor bortezomib in patients with advanced solid tumors with observations in androgen-independent prostate cancerChristos N Papandreou, Danai D Daliani, Darrell Nix, et al.Pageof 4